See the DrugPatentWatch profile for Midodrine
How does midodrine work in the body?
Midodrine is an oral prodrug. After you take it, your body converts it into its active metabolite, desglymidodrine. That active metabolite stimulates alpha-1 adrenergic receptors on blood vessels, which causes vasoconstriction (narrowing of peripheral blood vessels). As a result, blood pressure rises and blood can return more effectively from the legs to the rest of the circulation, reducing symptoms related to low blood pressure—especially when standing.
Why does it raise blood pressure?
By activating alpha-1 receptors on vascular smooth muscle, desglymidodrine increases peripheral vascular resistance. Increased resistance means higher systemic blood pressure, which helps counter orthostatic hypotension (a drop in blood pressure when moving from lying or sitting to standing).
What does “prodrug” mean for midodrine’s effect?
Because midodrine itself is inactive until it is metabolized to desglymidodrine, the clinical effect depends on that conversion in the body. That is why the drug is described as a prodrug and why the blood-pressure–raising activity is linked to its active metabolite.
What symptoms is midodrine typically used for (mechanism-aligned)?
The vasoconstriction and blood-pressure support from alpha-1 stimulation are most relevant to conditions where the main problem is inadequate blood pressure regulation on standing. That clinical match is what drives its use for orthostatic hypotension and related forms of low blood pressure.